Sweden

NORDIC REGIONAL OFFICE

Gilead Sciences Sweden AB
Solna Gate
Hemvarnsgatan 9
171 54
Solna
Sweden

Phone: 46 8 5057 1800 46 8 5057 1800

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.

Gilead’s operation in Sweden is responsible for sales and marketing support for Gilead’s products throughout the country.

Read more about Transparency Reporting

Relationships with Patient Organizations

Gilead provided support to the following patient organisations in 2017. The information is correct at the time of writing, September 2018. The information is subject to change and periodic updates. For a listing of previous years’ grants, click here.

Recipient Description of Activity Amount Funded SEK
BLOODCANCER-FORBUNDET Sponsorship of "Nationella KLL Dagen". 24,225.00
BLOODCANCER-FORBUNDET Grant to cover part of direct costs for an educational patient meeting with focus on immune therapy. 17,000.00
BLOODCANCER-FORBUNDET Grant to cover part of the direct costs for six information meetings on chronic blood cancer. 25,190.00
BLOODCANCER-FORBUNDET Grant to cover part of the direct costs for an educational meeting for patients on International Lymphoma Day. 10,000.00
BLOODCANCER-FORBUNDET Grant to cover part of the costs for a speaker and moderator at a round table meeting. 4,775.00
HIV SWEDEN Financial support to cover the costs a seminar on REFORM-ACT. 62,500.00
NOAKS ARK Financial support for printing of the "HIV Report". 43,064.50
HIV SWEDEN Financial support to print a White Paper focusing on addressing questions around securing long term health in Sweden. 6,437.50

This page is intended for visitors outside of the United States.